Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 9;13(3):e1006654. doi: 10.1371/journal.pgen.1006654

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Mapes et al

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Fig 6 — (A) Cuzd1^(-/-) mammary gland morphology in response to hormonal treatment. Cuzd1^(+/+) and Cuzd1^(-/-) mice (n = 5) were treated with a vehicle control (a and b) or E+P+PRL (c and d) for 3d. Whole mount analysis of no. 4 inguinal mammary glands of Cuzd1^(+/+) and Cuzd1^(-/-) mice after 3d of hormone treatment. Magnification 6.3x. (B) Analysis of CUZD1 expression. Mammary tissue sections obtained from Cuzd1^(+/+) (a and c) and Cuzd1^(-/-) (b and d) mice were subjected to IHC using an antibody specific for CUZD1. (C) Activation of STAT5. Mammary tissue sections obtained from Cuzd1^(+/+) (a and c) and Cuzd1^(-/-) (b and d) mice were subjected to IHC using an antibody specific for pSTAT5. (D) Analysis of EREG expression. Mammary tissue sections obtained from Cuzd1^(+/+) (a) and Cuzd1^(-/-) (b) mice were subjected to IHC using an antibody specific for EREG. Magnification 20x.